title: Dense chitosan surgical membranes produced by a coincident compression-dehydration process.
abstract: High density chitosan membranes were produced via a novel manufacturing process and used as implantable resorbable surgical membranes. The innovative method utilizes the following three sequential steps: (1) casting an acidic chitosan solution within a silicon mold, followed by freezing; (2) neutralizing the frozen acidic chitosan solution in alkaline solution to facilitate polymerization; and (3) applying coincident compression-dehydration under a vacuum. Resulting membranes of 0.2-0.5 mm thickness have densities as high as 1.6 g/cm(3). Inclusion of glycerol prior to the compression-dehydration step provides additional physical and clinical handling benefits. The biomaterials exhibit tensile strength with a maximum load as high as 10.9 N at ~2.5 mm width and clinically relevant resistance to suture pull-out with a maximum load as high as 2.2 N. These physical properties were superior to those of a commercial reconstituted collagen membrane. The dense chitosan membranes have excellent clinical handling characteristics, such as pliability and 'memory' when wet. They are semipermeable to small molecules, biodegradable in vitro in lysozyme solution, and the rates of degradation are inversely correlated to the degree of deacetylation. Furthermore, the dense chitosan membranes are biocompatible and resorbable in vivo as demonstrated in a rat oral wound healing model. The unique combination of physical, in vitro, in vivo, and clinical handling properties demonstrate the high utility of dense chitosan membranes produced by this new method. The materials may be useful as surgical barrier membranes, scaffolds for tissue engineering, wound dressings, and as delivery devices for active ingredients.
authors.affiliation: Agenta Biotechnologies Inc, 1500 1st Avenue North, Unit 31, Birmingham, AL 35203, USA. dooley@agentabio.com
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Dooley
authors.forename: April L
authors.initials: AL
authors.lastname: Ellis
authors.forename: Maria
authors.initials: M
authors.lastname: Belousova
authors.forename: Don
authors.initials: D
authors.lastname: Petersen
authors.forename: Arthur A
authors.initials: AA
authors.lastname: DeCarlo
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry* / Q000378:metabolism; D002460:Cell Line; D048271:Chitosan / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D008297:Male; D008422:Materials Testing; D008567:Membranes, Artificial; D009113:Muramidase / Q000378:metabolism; D010539:Permeability; D051381:Rats; D011917:Rats, Inbred Lew; D013718:Tensile Strength; D014945:Wound Healing
chemical_list: D001672:Biocompatible Materials; D008567:Membranes, Artificial; D048271:Chitosan; D009113:Muramidase
references.citation: Biomaterials. 2006 Sep;27(27):4815-24
references.pmid: 16725196
references.citation: Gene Ther. 2009 Sep;16(9):1097-110
references.pmid: 19440230
references.citation: Expert Opin Drug Deliv. 2009 Mar;6(3):239-53
references.pmid: 19290841
references.citation: Biomaterials. 2001 Feb;22(4):331-6
references.pmid: 11205436
references.citation: Regul Toxicol Pharmacol. 2010 Apr;56(3):290-9
references.pmid: 19788905
references.citation: Methods Enzymol. 2009;465:289-312
references.pmid: 19913173
references.citation: Vaccine. 2005 Aug 15;23(35):4367-74
references.pmid: 15916838
references.citation: Drug Dev Ind Pharm. 2004 Apr;30(4):397-404
references.pmid: 15132182
references.citation: Pharm Res. 1998 Sep;15(9):1326-31
references.pmid: 9755881
references.citation: Int J Pharm. 2007 Aug 1;340(1-2):134-42
references.pmid: 17459620
references.citation: Adv Drug Deliv Rev. 2010 Jan 31;62(1):100-17
references.pmid: 19958805
references.citation: Int J Nanomedicine. 2012;7:25-34
references.pmid: 22275820
references.citation: Int J Nanomedicine. 2012;7:763-71
references.pmid: 22359454
references.citation: J Pharm Pharmacol. 2003 Nov;55(11):1451-63
references.pmid: 14713355
references.citation: Adv Drug Deliv Rev. 2004 Jun 23;56(10):1467-80
references.pmid: 15191793
references.citation: Pharm Res. 1994 Aug;11(8):1186-9
references.pmid: 7971722
references.citation: EXS. 1999;87:305-13
references.pmid: 10906969
references.citation: J Biomed Mater Res A. 2009 Aug;90(2):564-76
references.pmid: 18563823
references.citation: Biomaterials. 2001 Jan;22(2):165-73
references.pmid: 11101160
references.citation: Biotechnol Adv. 2011 May-Jun;29(3):322-37
references.pmid: 21262336
references.citation: J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):461-6
references.pmid: 19145627
references.citation: J Biomater Sci Polym Ed. 2008;19(4):453-66
references.pmid: 18318958
references.citation: J Biomed Mater Res B Appl Biomater. 2004 May 15;69(2):216-22
references.pmid: 15116411
references.citation: Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1416-25
references.pmid: 16565375
references.citation: Cell Mol Life Sci. 1997 Feb;53(2):131-40
references.pmid: 9118001
references.citation: J Control Release. 2005 Jan 3;101(1-3):151-62
references.pmid: 15588901
references.citation: Eur J Pharm Biopharm. 2009 Feb;71(2):257-63
references.pmid: 18955137
references.citation: J Control Release. 2003 Apr 29;89(2):151-65
references.pmid: 12711440
references.citation: Int J Pharm. 2009 Dec 1;382(1-2):205-14
references.pmid: 19660537
references.citation: Mar Drugs. 2010 Jun 25;8(7):1962-87
references.pmid: 20714418
references.citation: Biomaterials. 2001 Feb;22(3):261-8
references.pmid: 11197501
references.citation: Pediatr Allergy Immunol. 2009 Nov;20(7):686-92
references.pmid: 19594854
references.citation: Mar Drugs. 2010 Feb 21;8(2):292-312
references.pmid: 20390107
references.citation: Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96
references.pmid: 11516781
references.citation: Biomaterials. 1989 Nov;10(9):598-603
references.pmid: 2611308
references.citation: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2921-8
references.pmid: 17048499
references.citation: J Biomed Mater Res A. 2006 Feb;76(2):408-15
references.pmid: 16270348
references.citation: Int J Pharm. 2001 Aug 14;224(1-2):159-68
references.pmid: 11472825
references.citation: Am J Rhinol Allergy. 2010 Jan-Feb;24(1):70-5
references.pmid: 20109331
references.citation: Pediatr Allergy Immunol. 2005 Nov;16(7):567-73
references.pmid: 16238581
references.citation: J Control Release. 2006 Apr 10;111(3):299-308
references.pmid: 16481062
references.citation: Pharm Res. 2006 Mar;23(3):549-56
references.pmid: 16525861
references.citation: J Biomed Mater Res B Appl Biomater. 2007 Feb;80(2):394-405
references.pmid: 16850463
references.citation: Ann N Y Acad Sci. 2001 Nov;944:388-97
references.pmid: 11797688
references.citation: Carbohydr Res. 1997 Mar 26;299(1-2):99-101
references.pmid: 9129298
references.citation: Expert Opin Drug Deliv. 2005 Sep;2(5):843-54
references.pmid: 16296782
references.citation: ACS Appl Mater Interfaces. 2012 May;4(5):2618-29
references.pmid: 22489770
references.citation: Int J Food Microbiol. 2002 Mar 25;74(1-2):65-72
references.pmid: 11929171
references.citation: Eur J Pharm Sci. 2003 Sep;20(1):73-81
references.pmid: 13678795